Parkinson’s Psychosis and Dopamine Dysregulation Cas... \| MDster                                                show = false, 1500)" role="region" aria-label="Connection status" aria-atomic="true" x-bind:aria-live="offline ? 'assertive' : 'polite'" x-bind:aria-hidden="(!show).toString()" class="offline-banner max-w-sm mx-auto px-4 py-3 text-sm font-bold text-center text-white rounded-full shadow-lg transition-all duration-500 ease-in-out" :class="{ 'hidden-state': !show, 'bg-error': offline, 'bg-success': !offline }"&gt;      You are offline 

     Back online! 

  [  MDster home ](/ "MDster home") 

  Specialities     [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Neurology ](https://mdster.com/speciality/neurology) [ Obstetrics &amp; Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) 

 [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) 

 Menu      

  Specialities     [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Neurology ](https://mdster.com/speciality/neurology) [ Obstetrics &amp; Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) 

 [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) 

 [     Login    ](https://mdster.com/auth/login) 

 1. [        Home  ](https://mdster.com)
2. [   Blog  ](https://mdster.com/blog)
3. [   Case Discussion  ](https://mdster.com/blog?category=case-discussion)
4. Parkinson’s Disease Psychosis, Gambling, and Dopamine Dysregulation

  [ Case Discussion ](https://mdster.com/blog?category=case-discussion)  

 Parkinson’s Disease Psychosis, Gambling, and Dopamine Dysregulation 
=====================================================================

 A case discussion on separating overlapping dopaminergic syndromes while protecting motor function

  [     MDster Editorial Team ](https://mdster.com/about) ·      Oct 30, 2026  ·      7 min read  ·       31  

  [     Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) \| [Corrections Policy](https://mdster.com/corrections) 

    [ Case Discussion ](https://mdster.com/blog?tag=case-discussion) [ Psychiatry ](https://mdster.com/blog?tag=psychiatry) [ Psychopharmacology ](https://mdster.com/blog?tag=psychopharmacology) [ Consultation-Liaison Psychiatry ](https://mdster.com/blog?tag=consultation-liaison-psychiatry) [ Parkinson’s Disease ](https://mdster.com/blog?tag=parkinsons-disease)  

                                                          ![Parkinson’s Disease Psychosis, Gambling, and Dopamine Dysregulation](https://mdster.com/storage/blog/images/parkinsons-disease-psychosis-gambling-and-dopamine-dysregulation.png)  

    Share this article 

        Share this post 

 On this page

 1. [ Reading the behavioral pattern ](#reading-the-behavioral-pattern)
2. [ Three behaviors, three clinical labels ](#three-behaviors-three-clinical-labels)
3. [ Are the hallucinations Parkinson’s disease psychosis? ](#are-the-hallucinations-parkinsons-disease-psychosis)
4. [ Differential worth defending at the bedside ](#differential-worth-defending-at-the-bedside)
5. [ A supervised plan, not covert withdrawal ](#a-supervised-plan-not-covert-withdrawal)
6. [ Psychosis after pramipexole withdrawal ](#psychosis-after-pramipexole-withdrawal)
7. [ When depression changes the priorities ](#when-depression-changes-the-priorities)
8. [ Key Points for Board Exams ](#key-points-for-board-exams)
9. [ Frequently Asked Questions ](#blog-faqs)
10. [ References ](#references-heading)

 On this page

 1. [ Reading the behavioral pattern ](#reading-the-behavioral-pattern)
2. [ Three behaviors, three clinical labels ](#three-behaviors-three-clinical-labels)
3. [ Are the hallucinations Parkinson’s disease psychosis? ](#are-the-hallucinations-parkinsons-disease-psychosis)
4. [ Differential worth defending at the bedside ](#differential-worth-defending-at-the-bedside)
5. [ A supervised plan, not covert withdrawal ](#a-supervised-plan-not-covert-withdrawal)
6. [ Psychosis after pramipexole withdrawal ](#psychosis-after-pramipexole-withdrawal)
7. [ When depression changes the priorities ](#when-depression-changes-the-priorities)
8. [ Key Points for Board Exams ](#key-points-for-board-exams)
9. [ Frequently Asked Questions ](#blog-faqs)
10. [ References ](#references-heading)

A wife asks whether she should secretly stop her husband’s pramipexole after his gambling exhausts their savings. He has also begun taking extra doses, sorting tools for hours, and seeing frightening strangers in their living room. Abruptly removing dopaminergic treatment could worsen his movement disorder and precipitate withdrawal; continuing it unchanged risks further harm. [\[1\]](#cite-1 "Reference &#91;1&#93;")

Reading the behavioral pattern
------------------------------

The 62-year-old takes carbidopa/levodopa four times daily and pramipexole three times daily. He is oriented, with resting tremor and bilateral rigidity; CBC, metabolic panel, and urinalysis are unrevealing. Those results narrow the immediate workup but do not, by themselves, exclude delirium. [\[1\]](#cite-1 "Reference &#91;1&#93;")

### Three behaviors, three clinical labels

- **Impulse-control disorder (ICD)** explains gambling despite escalating financial consequences. Dopamine agonists are an important risk factor, although other dopaminergic therapies can also contribute. [\[1\]](#cite-1 "Reference &#91;1&#93;")
- **Possible dopamine dysregulation syndrome (DDS)** describes compulsive use of dopaminergic medication beyond motor need. Early refills and extra pramipexole raise concern, but establish the pattern and motivation before assigning the diagnosis: DDS is more strongly associated with levodopa than with oral agonists. [\[2\]](#cite-2 "Reference &#91;2&#93;")
- **Punding** is the repetitive, complex, seemingly purposeless tool-sorting. It can coexist with ICD and DDS but is not another name for gambling. [\[2\]](#cite-2 "Reference &#91;2&#93;")

Mesolimbic reward circuitry, particularly dopamine signaling involving the nucleus accumbens, links dopaminergic treatment to reinforcement and medication-seeking. That account does not reduce every behavior to one mechanism: motor fluctuations, fear of freezing, and the drug’s rewarding effects all deserve assessment. [\[2\]](#cite-2 "Reference &#91;2&#93;")

Are the hallucinations Parkinson’s disease psychosis?
-----------------------------------------------------

Formed visual hallucinations in a person with established Parkinson’s disease suggest Parkinson’s disease psychosis, potentially exacerbated by medication. Their frightening nature makes observation alone inappropriate here. First check the course of attention and consciousness, recent medication changes, sleep, sensory impairment, pain, and other medical precipitants. [\[1\]](#cite-1 "Reference &#91;1&#93;")

### Differential worth defending at the bedside

- **Delirium:** Look for fluctuating attention or arousal and a newly emerging medical or toxic cause; normal routine laboratories cannot rule it out. [\[1\]](#cite-1 "Reference &#91;1&#93;")
- **Parkinson’s disease dementia:** Assess cognition and function longitudinally rather than inferring dementia from hallucinations alone. [\[1\]](#cite-1 "Reference &#91;1&#93;")
- **Medication-associated psychosis:** Review prescribed and actual dopaminergic doses, including unscheduled doses and recent additions. [\[1\]](#cite-1 "Reference &#91;1&#93;")

Document hallucination frequency, distress, insight, sleep disruption, and safety risk alongside a focused cognitive assessment. Ask the patient and wife separately about gambling losses, access to funds, and medication use; concealed ICD symptoms are possible. [\[1\]](#cite-1 "Reference &#91;1&#93;")

A supervised plan, not covert withdrawal
----------------------------------------

Thank the wife for disclosing the harm, but do not endorse secretly withholding medication. Speak with the patient, assess decision-making capacity for the relevant decisions, and agree on a plan with the Parkinson’s specialist. With his participation, consider practical safeguards for spending and dispensing while arranging prompt follow-up. [\[1\]](#cite-1 "Reference &#91;1&#93;")

1. Treat any identified medical trigger and reconcile what he actually takes against the prescription. [\[1\]](#cite-1 "Reference &#91;1&#93;")
2. **Gradually reduce pramipexole first**, with specialist input. Track gambling, hallucinations, rigidity, bradykinesia, and functional mobility; do not abruptly remove the drug or automatically increase levodopa to compensate. [\[1\]](#cite-1 "Reference &#91;1&#93;")
3. Warn about dopamine agonist withdrawal syndrome: anxiety, dysphoria, pain, autonomic symptoms, and cravings may emerge during tapering. Arrange close review and assess suicidality if mood deteriorates. [\[3\]](#cite-3 "Reference &#91;3&#93;")
4. If problematic ICD persists despite medication modification, consider specialist CBT directed at ICD alongside financial and caregiver support. [\[1\]](#cite-1 "Reference &#91;1&#93;")

> **Clinical pearl:** Improvement in gambling after agonist withdrawal does not prove persistent hallucinations are harmless—or that further dopaminergic reduction is motorically tolerable. Reassess each symptom and its treatment trade-off separately. [\[1\]](#cite-1 "Reference &#91;1&#93;")

Psychosis after pramipexole withdrawal
--------------------------------------

Suppose gambling resolves but frightening hallucinations persist and a cautious quetiapine trial fails. Low-dose clozapine has strong trial evidence for Parkinson’s disease psychosis and generally does not worsen parkinsonism; one randomized trial also found tremor improvement. Its antitremor effect should **not** be presented as equivalent to benztropine. Quetiapine is often considered because it avoids clozapine’s blood-monitoring burden, but its efficacy evidence is weaker. [\[4\]](#cite-4 "Reference &#91;4&#93;")

Clozapine may be initiated at 6.25 mg daily with cautious specialist titration. Obtain a baseline absolute neutrophil count (ANC) and continue monitoring because severe neutropenia remains a potentially fatal risk. **U.S. update:** the FDA eliminated the clozapine REMS effective June 13, 2025; REMS enrollment and ANC submission are no longer dispensing requirements, but the FDA still recommends ANC monitoring according to prescribing information. [\[5\]](#cite-5 "Reference &#91;5&#93;")

If he refuses blood draws, pimavanserin is a reasonable U.S.-approved alternative. Its predominantly 5-HT2A inverse-agonist/antagonist activity lacks appreciable D2 binding, avoiding direct dopamine blockade. Review QT risk and interacting drugs before prescribing; neither treatment choice eliminates the need to revisit cognition and medical causes. [\[6\]](#cite-6 "Reference &#91;6&#93;")

When depression changes the priorities
--------------------------------------

Months later, sustained low mood, anhedonia, and vegetative symptoms warrant assessment for major depression, suicidality, cognitive change, and residual agonist withdrawal. **Sertraline is a reasonable initial SSRI, not a uniquely mandated first-line Parkinson’s drug.** Venlafaxine has placebo-controlled evidence in Parkinson’s disease; duloxetine is another option, selected with attention to tolerability, comorbidity, and interactions. [\[7\]](#cite-7 "Reference &#91;7&#93;")

If depression becomes life-threatening because he stops eating, consider ECT rather than waiting through further ineffective trials. Explain the potential for post-treatment confusion or delirium, particularly with underlying cognitive impairment, and assess cognition before and during treatment. ECT’s cognitive risk is important, but it is not an automatic contraindication. [\[8\]](#cite-8 "Reference &#91;8&#93;")

Key Points for Board Exams
--------------------------

- Gambling, compulsive medication use, and punding are related but distinct dopaminergic complications. [\[2\]](#cite-2 "Reference &#91;2&#93;")
- Taper the dopamine agonist with specialist supervision; monitor both motor decline and withdrawal. [\[1\]](#cite-1 "Reference &#91;1&#93;")
- Persistent distressing psychosis may warrant clozapine or pimavanserin; preserve motor function and account for each drug’s monitoring risks. [\[4\]](#cite-4 "Reference &#91;4&#93;")
- In severe depression with refusal of food, weigh timely ECT against individualized cognitive and delirium risk. [\[8\]](#cite-8 "Reference &#91;8&#93;")

The central decision is not whether psychiatric symptoms or mobility matter more. It is how to reduce reward-related harm and psychosis without trading them for avoidable withdrawal, immobility, or cognitive injury.

 Frequently Asked Questions 
----------------------------

###     Does taking extra pramipexole establish dopamine dysregulation syndrome?             

No. It raises concern, but assess repeated compulsive overuse and its consequences, while distinguishing it from dosing driven by motor fluctuations or fear of freezing.

###     Can the family stop pramipexole immediately to prevent more gambling?             

They should seek urgent specialist review rather than withhold it covertly or abruptly; a supervised taper allows monitoring for withdrawal and motor deterioration.

###     Does clozapine still require REMS registration in the United States?             

No. The FDA removed REMS in June 2025, but still recommends baseline and ongoing ANC monitoring because severe neutropenia remains a risk.

###     What is the principal ECT concern if this patient has cognitive impairment?             

Post-treatment confusion or delirium warrants particular attention. Assess baseline cognition, discuss individual risks, and monitor cognition during treatment.

 References  (10)  
-------------------

 1. 1.  [ NICE. Parkinson’s disease in adults, guideline NG71.     ](https://www.nice.org.uk/guidance/ng71/chapter/Recommendations)   [↩](#cite-ref-1-1 "Back to text")
2. 2.  [ pubmed.ncbi.nlm.nih.gov/19173374     ](https://pubmed.ncbi.nlm.nih.gov/19173374/)   [↩](#cite-ref-2-1 "Back to text")
3. 3.  [ pubmed.ncbi.nlm.nih.gov/23686524     ](https://pubmed.ncbi.nlm.nih.gov/23686524/)   [↩](#cite-ref-3-1 "Back to text")
4. 4.  [ International Parkinson and Movement Disorder Society. Update on Treatments for Non-Motor Symptoms of Parkinson’s Disease, 2019.     ](https://www.movementdisorders.org/MDS-Files1/Resources/PDFs/Seppi_et_al-2019-Movement_Disorders.pdf)   [↩](#cite-ref-4-1 "Back to text")
5. 5.  [ pubmed.ncbi.nlm.nih.gov/10072410     ](https://pubmed.ncbi.nlm.nih.gov/10072410/)   [↩](#cite-ref-5-1 "Back to text")
6. 6.  [ DailyMed. NUPLAZID (pimavanserin) prescribing information, revised April 2026.     ](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e6bea44-57d6-4bac-9328-46e1ee59f83b)   [↩](#cite-ref-6-1 "Back to text")
7. 7.  [ www.nice.org.uk/guidance/cg91/chapter/Recommendations     ](https://www.nice.org.uk/guidance/cg91/chapter/Recommendations)   [↩](#cite-ref-7-1 "Back to text")
8. 8.  [ www.nice.org.uk/guidance/NG222/chapter/recommendations     ](https://www.nice.org.uk/guidance/NG222/chapter/recommendations)   [↩](#cite-ref-8-1 "Back to text")
9. 9.  [ FDA. FDA removes the clozapine REMS program, 2025.     ](https://www.fda.gov/drugs/drug-safety-and-availability/fda-removes-risk-evaluation-and-mitigation-strategy-rems-program-antipsychotic-drug-clozapine)
10. 10.  [ NICE. Depression in adults: treatment and management, guideline NG222.     ](https://www.nice.org.uk/guidance/ng222/chapter/Recommendations)

Keep going

 Build momentum in Psychiatry with a focused study pathway 
-----------------------------------------------------------

 - Exam‑style questions for Psychiatry
- Smart review to target weak topics
- Progress tracking that keeps you accountable

 [     Start your free trial ](https://mdster.com/user/dashboard)  [     Explore Psychiatry ](https://mdster.com/speciality/psychiatry)  

   [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features)  

 No credit card required. Full access to all features\*. No commitment. Cancel anytime.

 \*AI SOE Examiner is limited to 10 cases monthly for Advanced &amp; Bundle subscribers.

   Explore topics:  [ # Case Discussion ](https://mdster.com/blog?tag=case-discussion) [ # Psychiatry ](https://mdster.com/blog?tag=psychiatry) [ # Psychopharmacology ](https://mdster.com/blog?tag=psychopharmacology) [ # Consultation-Liaison Psychiatry ](https://mdster.com/blog?tag=consultation-liaison-psychiatry) [ # Parkinson’s Disease ](https://mdster.com/blog?tag=parkinsons-disease)  

  [     Back to all posts ](https://mdster.com/blog) 

 Discussion  ()  
-----------------

 Join the discussion

 [     Log in ](https://mdster.com/auth/login) or [     Sign up ](https://mdster.com/auth/register) 

No comments yet

Be the first to share your thoughts!

    ![]()     

More in Case Discussion
-----------------------

 [ See all     ](https://mdster.com/blog?category=case-discussion) 

  [###  Lung Transplant Anesthesia: RV Failure, ECMO, and Graft Dysfunction 

      6 min read       Oct 28, 2026

     ](https://mdster.com/blog/lung-transplant-anesthesia-rv-failure-ecmo-and-graft-dysfunction) [###  Schizoaffective Disorder and Olanzapine: A Metabolic Risk Case 

      6 min read       Oct 26, 2026

     ](https://mdster.com/blog/schizoaffective-disorder-and-olanzapine-a-metabolic-risk-case) [###  Suicide Risk Assessment in an Intoxicated Patient With Depression 

      7 min read       Oct 22, 2026

     ](https://mdster.com/blog/suicide-risk-assessment-in-an-intoxicated-patient-with-depression)  

Related Posts
-------------

  [                                ![Lung Transplant Anesthesia: RV Failure, ECMO, and Graft Dysfunction](https://mdster.com/storage/blog/images/lung-transplant-anesthesia-rv-failure-ecmo-and-graft-dysfunction.png)         Case Discussion 

###  Lung Transplant Anesthesia: RV Failure, ECMO, and Graft Dysfunction 

 A patient with severe pulmonary hypertension deteriorates during lung transplantation. Work through RV rescue, ECMO selection, anastomotic assessment, and graft protection.

     6 min read 

     0 comments 

 ](https://mdster.com/blog/lung-transplant-anesthesia-rv-failure-ecmo-and-graft-dysfunction) [                                ![Schizoaffective Disorder and Olanzapine: A Metabolic Risk Case](https://mdster.com/storage/blog/images/schizoaffective-disorder-and-olanzapine-a-metabolic-risk-case.png)         Case Discussion 

###  Schizoaffective Disorder and Olanzapine: A Metabolic Risk Case 

 A woman with mania, psychosis, and suspected medication nonadherence also has diabetes-range results. Work through the diagnosis, acute agitation, and a safer long-term plan.

     6 min read 

     0 comments 

 ](https://mdster.com/blog/schizoaffective-disorder-and-olanzapine-a-metabolic-risk-case) [                                ![Suicide Risk Assessment in an Intoxicated Patient With Depression](https://mdster.com/storage/blog/images/suicide-risk-assessment-in-an-intoxicated-patient-with-depression.png)         Case Discussion 

###  Suicide Risk Assessment in an Intoxicated Patient With Depression 

 An older man denies suicidal intent while intoxicated, but collateral history reveals possible preparatory behavior and a loaded rifle. How should clinicians assess and manage his risk?

     7 min read 

     0 comments 

 ](https://mdster.com/blog/suicide-risk-assessment-in-an-intoxicated-patient-with-depression) [                                ![Thyroid Storm or Malignant Hyperthermia? An Intraoperative Crisis](https://mdster.com/storage/blog/images/thyroid-storm-or-malignant-hyperthermia-an-intraoperative-crisis.png)         Case Discussion 

###  Thyroid Storm or Malignant Hyperthermia? An Intraoperative Crisis 

 A patient with untreated Graves’ disease develops fever, tachycardia, and rising ETCO₂ during laparoscopy. Work through the competing diagnoses and time-critical treatment.

     6 min read 

     0 comments 

 ](https://mdster.com/blog/thyroid-storm-or-malignant-hyperthermia-an-intraoperative-crisis) [                                ![Negative Transference and Depression Relapse: A Psychiatry Case](https://mdster.com/storage/blog/images/negative-transference-and-depression-relapse-a-psychiatry-case.png)         Case Discussion 

###  Negative Transference and Depression Relapse: A Psychiatry Case 

 A patient’s depression worsens after a perceived rejection by her therapist. This case examines safety assessment, transference, countertransference, and medication decisions.

     6 min read 

     0 comments 

 ](https://mdster.com/blog/negative-transference-and-depression-relapse-a-psychiatry-case) [                                ![Postoperative Airway Edema After Prone Spine Surgery: Extubation Case](https://mdster.com/storage/blog/images/postoperative-airway-edema-after-prone-spine-surgery-extubation-case.png)         Case Discussion 

###  Postoperative Airway Edema After Prone Spine Surgery: Extubation Case 

 A ten-hour prone spinal fusion ends with facial edema and a request for extubation. Follow the airway assessment, delayed-extubation plan, and response to stridor.

     6 min read 

     0 comments 

 ](https://mdster.com/blog/postoperative-airway-edema-after-prone-spine-surgery-extubation-case)  

  [  MDster home ](/ "MDster home")

 Master your medical exams with evidence-based learning.

 [    Download on the App Store 

 ](https://apps.apple.com/app/id6759168258) [       GET IT ON Google Play 

 ](https://play.google.com/store/apps/details?id=com.mdster.app) 

Platform

- [Home](https://mdster.com)
- [Features](https://mdster.com/features)
- [Pricing](https://mdster.com/pricing)
- [About](https://mdster.com/about)

Resources

- [Blog](https://mdster.com/blog)
- [Curriculum](https://mdster.com/curriculum)
- [Dashboard](https://mdster.com/user/dashboard)

Support

- [Contact](https://mdster.com/contact)
- [Legal &amp; Policies](https://mdster.com/legal)
- [Medical Reviewers](https://mdster.com/medical-reviewers)

 © 2026 MDster

  [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy)  [    ](https://apps.apple.com/app/id6759168258) [    ](https://play.google.com/store/apps/details?id=com.mdster.app) 

     reCAPTCHA 

 Protected by reCAPTCHA.

 Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply.

Cookie Consent
--------------

 We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) &amp; [ Privacy Policy ](https://mdster.com/privacy)

  Accept
